Neuroendocrine Tumors (NETs) Treatment Market Report

China Neuroendocrine Tumors (NETs) Treatment Industry Market Research Report 2023-2029

  • POSTDATE：Sep 15, 2023
  • PAGES：168
  • REPORT CODE：GMM1798352
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Neuro Emotional Technique (NET) is a psycho-emotional therapy based on the physiological foundations of stress-related responses. As discovered in the late 1970’s, emotional responses are composed of neuropeptides (amino acid chains) and their receptors, which lie on neurons and other cells of remote tissues in the body. The neuropeptides are ejected from the neuron and carry the encoded “information” to other sites within the body. These neuropeptides are in a category of neurochemicals known as Information Substances (IS). ISs are released at times of stress-related arousal and become attached to remotely-positioned neuroreceptors.

    This report elaborates on the current development of the Neuroendocrine Tumors (NETs) Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • IpsenPharma

    • AVEO Oncology

    • Progenics Pharmaceuticals

    • Hutchison MediPharma Limited

    • Boehringer Ingelheim International

    • Pfizer, Inc

    • Novartis AG

    By Type:

    • Other

    • Somatostatin Analogs (SSAs)

    • Targeted Therapy

    By Application:

    • Other

    • Clinics

    • Hospitals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Neuroendocrine Tumors (NETs) Treatment Market Overview 2018-2029

    • 1.1 China Neuroendocrine Tumors (NETs) Treatment Industry Development Overview

    • 1.2 China Neuroendocrine Tumors (NETs) Treatment Industry Development History

    • 1.3 China Neuroendocrine Tumors (NETs) Treatment Industry Market Size (2018-2029)

    • 1.4 China Neuroendocrine Tumors (NETs) Treatment Market Analysis by Type from Production Side

      • 1.4.1 China Neuroendocrine Tumors (NETs) Treatment Production Volume, Production Value and Growth Rate of Other (2018-2029)

      • 1.4.2 China Neuroendocrine Tumors (NETs) Treatment Production Volume, Production Value and Growth Rate of Somatostatin Analogs (SSAs) (2018-2029)

      • 1.4.3 China Neuroendocrine Tumors (NETs) Treatment Production Volume, Production Value and Growth Rate of Targeted Therapy (2018-2029)

    • 1.5 China Neuroendocrine Tumors (NETs) Treatment Market Analysis by Application from Consumption End

      • 1.5.1 China Neuroendocrine Tumors (NETs) Treatment Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.2 China Neuroendocrine Tumors (NETs) Treatment Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

      • 1.5.3 China Neuroendocrine Tumors (NETs) Treatment Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • 1.6 China Neuroendocrine Tumors (NETs) Treatment Market Analysis by Region

      • 1.6.1 North China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate from 2018-2029

    Chapter 2 China Neuroendocrine Tumors (NETs) Treatment Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Neuroendocrine Tumors (NETs) Treatment Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Neuroendocrine Tumors (NETs) Treatment Market Status and Competition Analysis in 2023

      • 2.2.3 China Neuroendocrine Tumors (NETs) Treatment Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Neuroendocrine Tumors (NETs) Treatment Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Neuroendocrine Tumors (NETs) Treatment Industry Development

    Chapter 3 Neuroendocrine Tumors (NETs) TreatmentIndustry Chain Analysis

    • 3.1 Neuroendocrine Tumors (NETs) Treatment Industry Chain

    • 3.2 Neuroendocrine Tumors (NETs) Treatment Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Neuroendocrine Tumors (NETs) Treatment Market

    • 3.3 Neuroendocrine Tumors (NETs) Treatment Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Neuroendocrine Tumors (NETs) Treatment Market

    Chapter 4 China Neuroendocrine Tumors (NETs) Treatment Market, by Type

    • 4.1 China Neuroendocrine Tumors (NETs) Treatment Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Neuroendocrine Tumors (NETs) Treatment Total Production Volume and Growth Rate from Production Side

    • 4.5 China Neuroendocrine Tumors (NETs) Treatment Production Volume and Growth Rate, by Type

      • 4.5.1 China Neuroendocrine Tumors (NETs) Treatment Production Volume and Growth Rate of Other

      • 4.5.2 China Neuroendocrine Tumors (NETs) Treatment Production Volume and Growth Rate of Somatostatin Analogs (SSAs)

      • 4.5.3 China Neuroendocrine Tumors (NETs) Treatment Production Volume and Growth Rate of Targeted Therapy

    Chapter 5 China Neuroendocrine Tumors (NETs) Treatment Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Neuroendocrine Tumors (NETs) Treatment Total Market Size and Growth Rate from Consumption End

    • 5.5 China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate, by Application

      • 5.5.1 China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate of Other

      • 5.5.2 China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate of Clinics

      • 5.5.3 China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate of Hospitals

    Chapter 6 China Neuroendocrine Tumors (NETs) Treatment Market, by Region

    • 6.1 China Neuroendocrine Tumors (NETs) Treatment Production Volume and Production Value, by Region

    • 6.2 China Neuroendocrine Tumors (NETs) Treatment Sales Volume and Sales Value, by Region

    Chapter 7 North China Neuroendocrine Tumors (NETs) Treatment Market Analysis

    • 7.1 North China Neuroendocrine Tumors (NETs) Treatment Market, by Type

    • 7.2 North China Neuroendocrine Tumors (NETs) Treatment Market, by Application

    Chapter 8 Central China Neuroendocrine Tumors (NETs) Treatment Market Analysis

    • 8.1 Central China Neuroendocrine Tumors (NETs) Treatment Market, by Type

    • 8.2 Central China Neuroendocrine Tumors (NETs) Treatment Market, by Application

    Chapter 9 South China Neuroendocrine Tumors (NETs) Treatment Market Analysis

    • 9.1 South China Neuroendocrine Tumors (NETs) Treatment Market, by Type

    • 9.2 South China Neuroendocrine Tumors (NETs) Treatment Market, by Application

    Chapter 10 East China Neuroendocrine Tumors (NETs) Treatment Market Analysis

    • 10.1 East China Neuroendocrine Tumors (NETs) Treatment Market, by Type

    • 10.2 East China Neuroendocrine Tumors (NETs) Treatment Market, by Application

    Chapter 11 Northeast China Neuroendocrine Tumors (NETs) Treatment Market Analysis

    • 11.1 Northeast China Neuroendocrine Tumors (NETs) Treatment Market, by Type

    • 11.2 Northeast China Neuroendocrine Tumors (NETs) Treatment Market, by Application

    Chapter 12 Southwest China Neuroendocrine Tumors (NETs) Treatment Market Analysis

    • 12.1 Southwest China Neuroendocrine Tumors (NETs) Treatment Market, by Type

    • 12.2 Southwest China Neuroendocrine Tumors (NETs) Treatment Market, by Application

    Chapter 13 Northwest China Neuroendocrine Tumors (NETs) Treatment Market Analysis

    • 13.1 Northwest China Neuroendocrine Tumors (NETs) Treatment Market, by Type

    • 13.2 Northwest China Neuroendocrine Tumors (NETs) Treatment Market, by Application

    Chapter 14 Company Profiles

      • 14.1 IpsenPharma

        • 14.1.1 IpsenPharma Company Profile

        • 14.1.2 IpsenPharma Neuroendocrine Tumors (NETs) Treatment Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 AVEO Oncology

        • 14.2.1 AVEO Oncology Company Profile

        • 14.2.2 AVEO Oncology Neuroendocrine Tumors (NETs) Treatment Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Progenics Pharmaceuticals

        • 14.3.1 Progenics Pharmaceuticals Company Profile

        • 14.3.2 Progenics Pharmaceuticals Neuroendocrine Tumors (NETs) Treatment Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Hutchison MediPharma Limited

        • 14.4.1 Hutchison MediPharma Limited Company Profile

        • 14.4.2 Hutchison MediPharma Limited Neuroendocrine Tumors (NETs) Treatment Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Boehringer Ingelheim International

        • 14.5.1 Boehringer Ingelheim International Company Profile

        • 14.5.2 Boehringer Ingelheim International Neuroendocrine Tumors (NETs) Treatment Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Pfizer, Inc

        • 14.6.1 Pfizer, Inc Company Profile

        • 14.6.2 Pfizer, Inc Neuroendocrine Tumors (NETs) Treatment Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Novartis AG

        • 14.7.1 Novartis AG Company Profile

        • 14.7.2 Novartis AG Neuroendocrine Tumors (NETs) Treatment Market Performance

        • 14.7.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Neuroendocrine Tumors (NETs) Treatment Industry Research Conclusions

    • 15.2 Neuroendocrine Tumors (NETs) Treatment Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Neuroendocrine Tumors (NETs) Treatment Industry Market Size (2018-2029)

    • Figure China Neuroendocrine Tumors (NETs) Treatment Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China Neuroendocrine Tumors (NETs) Treatment Production Volume, Production Value and Growth Rate of Somatostatin Analogs (SSAs) (2018-2029)

    • Figure China Neuroendocrine Tumors (NETs) Treatment Production Volume, Production Value and Growth Rate of Targeted Therapy (2018-2029)

    • Figure China Neuroendocrine Tumors (NETs) Treatment Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China Neuroendocrine Tumors (NETs) Treatment Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • Figure China Neuroendocrine Tumors (NETs) Treatment Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure North China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate from 2018-2029

    • Figure Central China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate from 2018-2029

    • Figure South China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate from 2018-2029

    • Figure East China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate from 2018-2029

    • Figure Neuroendocrine Tumors (NETs) Treatment Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Neuroendocrine Tumors (NETs) Treatment Market Share by Type in 2018

    • Figure China Neuroendocrine Tumors (NETs) Treatment Market Share by Type in 2023

    • Figure China Neuroendocrine Tumors (NETs) Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Neuroendocrine Tumors (NETs) Treatment Production Volume and Growth Rate of Other (2018-2023)

    • Figure China Neuroendocrine Tumors (NETs) Treatment Production Volume and Growth Rate of Somatostatin Analogs (SSAs) (2018-2023)

    • Figure China Neuroendocrine Tumors (NETs) Treatment Production Volume and Growth Rate of Targeted Therapy (2018-2023)

    • Figure China Neuroendocrine Tumors (NETs) Treatment Market Share by Application in 2018

    • Figure China Neuroendocrine Tumors (NETs) Treatment Market Share by Application in 2023

    • Figure China Neuroendocrine Tumors (NETs) Treatment Total Market Size and Growth Rate from Consumption End

    • Figure China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate of Other (2018-2023)

    • Figure China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate of Clinics (2018-2023)

    • Figure China Neuroendocrine Tumors (NETs) Treatment Market Size and Growth Rate of Hospitals (2018-2023)

    • Table China Neuroendocrine Tumors (NETs) Treatment Production Volume by Region (2018-2023)

    • Table China Neuroendocrine Tumors (NETs) Treatment Production Volume Share by Region (2018-2023)

    • Figure China Neuroendocrine Tumors (NETs) Treatment Production Volume Share by Region (2018-2023)

    • Table China Neuroendocrine Tumors (NETs) Treatment Production Value by Region (2018-2023)

    • Table China Neuroendocrine Tumors (NETs) Treatment Production Value Share by Region (2018-2023)

    • Figure China Neuroendocrine Tumors (NETs) Treatment Production Value Share by Region (2018-2023)

    • Table China Neuroendocrine Tumors (NETs) Treatment Sales Volume by Region (2018-2023)

    • Table China Neuroendocrine Tumors (NETs) Treatment Sales Volume Share by Region (2018-2023)

    • Figure China Neuroendocrine Tumors (NETs) Treatment Sales Volume Share by Region (2018-2023)

    • Table China Neuroendocrine Tumors (NETs) Treatment Sales Value by Region (2018-2023)

    • Table China Neuroendocrine Tumors (NETs) Treatment Sales Value Share by Region (2018-2023)

    • Figure China Neuroendocrine Tumors (NETs) Treatment Sales Value Share by Region (2018-2023)

    • Table North China Neuroendocrine Tumors (NETs) Treatment Production Volume by Type (2018-2023)

    • Table North China Neuroendocrine Tumors (NETs) Treatment Production Volume Share by Type (2018-2023)

    • Figure North China Neuroendocrine Tumors (NETs) Treatment Production Volume Share by Type (2018-2023)

    • Table North China Neuroendocrine Tumors (NETs) Treatment Sales Volume by Application (2018-2023)

    • Table North China Neuroendocrine Tumors (NETs) Treatment Sales Volume Share by Application (2018-2023)

    • Figure North China Neuroendocrine Tumors (NETs) Treatment Sales Volume Share by Application (2018-2023)

    • Table Central China Neuroendocrine Tumors (NETs) Treatment Production Volume by Type (2018-2023)

    • Table Central China Neuroendocrine Tumors (NETs) Treatment Production Volume Share by Type (2018-2023)

    • Figure Central China Neuroendocrine Tumors (NETs) Treatment Production Volume Share by Type (2018-2023)

    • Table Central China Neuroendocrine Tumors (NETs) Treatment Sales Volume by Application (2018-2023)

    • Table Central China Neuroendocrine Tumors (NETs) Treatment Sales Volume Share by Application (2018-2023)

    • Figure Central China Neuroendocrine Tumors (NETs) Treatment Sales Volume Share by Application (2018-2023)

    • Table South China Neuroendocrine Tumors (NETs) Treatment Production Volume by Type (2018-2023)

    • Table South China Neuroendocrine Tumors (NETs) Treatment Production Volume Share by Type (2018-2023)

    • Figure South China Neuroendocrine Tumors (NETs) Treatment Production Volume Share by Type (2018-2023)

    • Table South China Neuroendocrine Tumors (NETs) Treatment Sales Volume by Application (2018-2023)

    • Table South China Neuroendocrine Tumors (NETs) Treatment Sales Volume Share by Application (2018-2023)

    • Figure South China Neuroendocrine Tumors (NETs) Treatment Sales Volume Share by Application (2018-2023)

    • Table East China Neuroendocrine Tumors (NETs) Treatment Production Volume by Type (2018-2023)

    • Table East China Neuroendocrine Tumors (NETs) Treatment Production Volume Share by Type (2018-2023)

    • Figure East China Neuroendocrine Tumors (NETs) Treatment Production Volume Share by Type (2018-2023)

    • Table East China Neuroendocrine Tumors (NETs) Treatment Sales Volume by Application (2018-2023)

    • Table East China Neuroendocrine Tumors (NETs) Treatment Sales Volume Share by Application (2018-2023)

    • Figure East China Neuroendocrine Tumors (NETs) Treatment Sales Volume Share by Application (2018-2023)

    • Table Northeast China Neuroendocrine Tumors (NETs) Treatment Production Volume by Type (2018-2023)

    • Table Northeast China Neuroendocrine Tumors (NETs) Treatment Production Volume Share by Type (2018-2023)

    • Figure Northeast China Neuroendocrine Tumors (NETs) Treatment Production Volume Share by Type (2018-2023)

    • Table Northeast China Neuroendocrine Tumors (NETs) Treatment Sales Volume by Application (2018-2023)

    • Table Northeast China Neuroendocrine Tumors (NETs) Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Neuroendocrine Tumors (NETs) Treatment Sales Volume Share by Application (2018-2023)

    • Table Southwest China Neuroendocrine Tumors (NETs) Treatment Production Volume by Type (2018-2023)

    • Table Southwest China Neuroendocrine Tumors (NETs) Treatment Production Volume Share by Type (2018-2023)

    • Figure Southwest China Neuroendocrine Tumors (NETs) Treatment Production Volume Share by Type (2018-2023)

    • Table Southwest China Neuroendocrine Tumors (NETs) Treatment Sales Volume by Application (2018-2023)

    • Table Southwest China Neuroendocrine Tumors (NETs) Treatment Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Neuroendocrine Tumors (NETs) Treatment Sales Volume Share by Application (2018-2023)

    • Table Northwest China Neuroendocrine Tumors (NETs) Treatment Production Volume by Type (2018-2023)

    • Table Northwest China Neuroendocrine Tumors (NETs) Treatment Production Volume Share by Type (2018-2023)

    • Figure Northwest China Neuroendocrine Tumors (NETs) Treatment Production Volume Share by Type (2018-2023)

    • Table Northwest China Neuroendocrine Tumors (NETs) Treatment Sales Volume by Application (2018-2023)

    • Table Northwest China Neuroendocrine Tumors (NETs) Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Neuroendocrine Tumors (NETs) Treatment Sales Volume Share by Application (2018-2023)

    • Table IpsenPharma Company Profile

    • Table IpsenPharma Neuroendocrine Tumors (NETs) Treatment Revenue, Price and Gross (2018-2023)

    • Table AVEO Oncology Company Profile

    • Table AVEO Oncology Neuroendocrine Tumors (NETs) Treatment Revenue, Price and Gross (2018-2023)

    • Table Progenics Pharmaceuticals Company Profile

    • Table Progenics Pharmaceuticals Neuroendocrine Tumors (NETs) Treatment Revenue, Price and Gross (2018-2023)

    • Table Hutchison MediPharma Limited Company Profile

    • Table Hutchison MediPharma Limited Neuroendocrine Tumors (NETs) Treatment Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim International Company Profile

    • Table Boehringer Ingelheim International Neuroendocrine Tumors (NETs) Treatment Revenue, Price and Gross (2018-2023)

    • Table Pfizer, Inc Company Profile

    • Table Pfizer, Inc Neuroendocrine Tumors (NETs) Treatment Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Neuroendocrine Tumors (NETs) Treatment Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US